Osstem Implant Co., Ltd. signed a stock purchase agreement to acquire Implacil de Bortoli - Material Odontológico S.A. for $89.8 million on April 13, 2024. The deal is seen as Osstem Implant's Bolt-on strategy. Funding for the transaction is expected to be provided through surplus cash from Osstem Implant's U.S. subsidiary, Hiossen, and the deal closing is expected by the end of May. The firms received advise from PwC accountant and Itau BBA as financial advisor.

Osstem Implant Co., Ltd. completed the acquisition of Implacil de Bortoli - Material Odontológico S.A. on June 21, 2024.